Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Muscular Atrophies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06955897
What this trial is testing

Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA

Who this might be right for
Spinal Muscular Atrophy
Columbia University 45
Not applicableStudy completedNCT06315673
What this trial is testing

Digital Assessment of Speech and Fine Motor Control in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy
Milton S. Hershey Medical Center 42
Testing effectiveness (Phase 2)Ended earlyNCT03437941
What this trial is testing

Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics 39
Testing effectiveness (Phase 2)Looking for participantsNCT06365788
What this trial is testing

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Universitaire Ziekenhuizen KU Leuven 53
Large-scale testing (Phase 3)Study completedNCT03306277
What this trial is testing

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Who this might be right for
SMA - Spinal Muscular AtrophyGene Therapy
Novartis Gene Therapies 22
Not applicableStudy completedNCT05366465
What this trial is testing

Quality of Life and Participation of the Adult with Spinal Muscular Atrophy in France

Who this might be right for
Spinal Muscular Atrophy
Hospices Civils de Lyon 149
Not applicableApproved For MarketingNCT04256265
What this trial is testing

An Expanded Access Program for Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Who this might be right for
Muscular Atrophy, Spinal
Genentech, Inc.
Not applicableLooking for participantsNCT05789758
What this trial is testing

Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

Who this might be right for
Muscular Atrophy, Spinal
Biogen 20
Not applicableUnknownNCT02309983
What this trial is testing

Activity Dependent Rehabilitation Model to Improve Bone and Muscle Outcomes

Who this might be right for
Disuse OsteoporosisAtrophy, DisuseNervous System+2 more
Kessler Foundation 21
Early research (Phase 1)Ended earlyNCT03381729
What this trial is testing

Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Novartis Gene Therapies 32
Very early researchEnrolling By InvitationNCT06888661
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy (SMA)
Guangzhou Jiayin Biotech Ltd 4
Not applicableStudy completedNCT03560661
What this trial is testing

Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisKennedy's Disease
Assistance Publique - Hôpitaux de Paris 71
Post-approval studies (Phase 4)Looking for participantsNCT05861986
What this trial is testing

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 28
Not applicableStudy completedNCT01166022
What this trial is testing

Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)

Who this might be right for
Spinal Muscular AtrophyNeuromuscular Disease
Columbia University 14
Not applicableActive Not RecruitingNCT04833348
What this trial is testing

Quantification of Motor Function in Infants With Spinal Muscular Atrophy Treated With Innovative Therapies

Who this might be right for
Spinal Muscular Atrophy
Assistance Publique - Hôpitaux de Paris 35
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Not applicableStudy completedNCT05430113
What this trial is testing

Spinal Cord Stimulation in Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 4
Marco Capogrosso 3
Not applicableStudy completedNCT02895789
What this trial is testing

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Who this might be right for
Spinal Muscular Atrophy Type 3Mitochondrial Myopathy
Columbia University 42
Not applicableLooking for participantsNCT05204017
What this trial is testing

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy+1 more
University of Alberta 150
Not applicableActive Not RecruitingNCT05117827
What this trial is testing

Pediatric Powered Wheelchair Standing Devices: An Exploratory Study

Who this might be right for
Cerebral PalsySpinal Muscular AtrophySpinal Cord Injuries+3 more
Grand Valley State University 4
Next Page